Featured Article

Mar 15, 2021 | TCTMD
PFO Closure for Stroke Is Safe, Effective at 5 Years: REDUCE

Five-year results from the randomized REDUCE trial show a continued benefit of patent foramen ovale (PFO) closure compared with antiplatelet therapy alone for the prevention of cryptogenic stroke.

Feb 1, 2021 | TCTMD
Infective Endocarditis in IV Drug Users Doesn’t Always Match Expectations

New data on infective endocarditis (IE) among people who inject drugs run counter to long-held stereotypes about the condition—for example, a sizeable proportion of cases affect the heart’s left side, occur in prosthetic valves, and arise from organisms other than Staphylococcus aureus.

Jan 7, 2021 | TCTMD
Checklist for Same-Day Discharge PCI Stresses Buy-In, and a Plan

While not intended to coincide with COVID-19, the timing of the document is “fortuitous,” given the shortage of hospital beds.

Dec 30, 2020 | TCTMD
CathPCI Model Fails to Capture Excess Bleeding Risk With PCI Plus TAVR

Combining PCI and TAVR significantly increases the risk of bleeding compared with a coronary intervention alone, and that excess hazard is not captured well by the CathPCI risk model, data from a large New York City hospital show.

Dec 24, 2020 | TCTMD
A Fresh Foray in the Salt Wars: Life Expectancy Higher With Greater Sodium Intake

Greater sodium intake on a national level is associated with a longer average life expectancy and reduced all-cause mortality, according to an ecological study based on data from 181 countries.

Nov 9, 2020 | TCTMD
Conversations in Cardiology: How to Juggle Two STEMIs at the Same Time

Morton Kern, MD, often engages his colleagues via email in brief, informal dialogue on clinically relevant topics in cardiology.

Sep 21, 2020 | TCTMD
Colchicine Shows Potential in Malignant Pericardial Effusion

The anti-inflammatory may improve outcomes after effective drainage of fluid, an observational study suggests.

Sep 14, 2020 | TCTMD
TAVR and Infective Endocarditis—Two Studies Address a Shifting Landscape

Medicare data confirm IE post-TAVR is decreasing in recent years, while another report hints TAVR itself could—in select cases—treat IE.

Sep 4, 2020 | TCTMD
Insights From a Deep Dive Into CV Risk Among Hospitalized COVID-19 Patients

Mirroring other cohorts around the globe, US patients hospitalized with COVID-19 experience a high rate of cardiovascular events, but careful chart review suggests that these same patients also have a high burden of cardiovascular risk factors to begin with, according to research presented during the virtual European Society of Cardiology (ESC) Congress 2020.

Aug 17, 2020 | TCTMD
‘Striking Similarities’ for COVID-19 Inflammatory Syndromes in Children, Adults

MIS-C and an adult myocarditis-like syndrome are likely on a shared spectrum of CV complications, researchers say.

Filter by Journal